Skip to search formSkip to main contentSkip to account menu

artemether / lumefantrine Oral Tablet [Coartem]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: The aim of the study was to investigate the therapeutic efficacy of Coartem® in the treatment of simple P. falciparum… 
2018
2018
Dihydroartemisinin–piperaquine (DP) is recommended for the treatment of uncomplicated malaria, used in efforts to contain… 
2016
2016
Background. Artemether-lumefantrine (AL) is widely adopted as first-line treatment for uncomplicated malaria. Lumefantrine (LUM… 
2015
2015
In general, safety data following exposure to drugs in the first trimester of pregnancy are scarce. More specifically, data on… 
2014
2014
SUMMARY Solid complexes of artemether and hydroxypropyl-β-cyclodextrin (HP-β-CD) were prepared at a molar ratio of 1:1, 1:2 and 1… 
2013
2013
BackgroundArtemether-lumefantrine (Coartem®; AL) is a standard of care for malaria treatment as an oral six-dose regimen, given… 
2010
2010
Background The years 1985 to 1988 and 1997 to 2001, were periods of high morbidity and mortality due to malaria in KwaZulu-Natal… 
2005
2005
Antimalarial drug resistance is becoming an increasingly important public health problem. There is a consensus among…